These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer. Han Y; Xiao H; Zhou Z; Yuan M; Zeng Y; Wu H; Fang Y Nucl Med Commun; 2015 Mar; 36(3):234-41. PubMed ID: 25460305 [TBL] [Abstract][Full Text] [Related]
4. PET/CT in non-small cell lung cancer staging-promises and problems. Devaraj A; Cook GJ; Hansell DM Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691 [TBL] [Abstract][Full Text] [Related]
5. Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. Søgaard R; Fischer BM; Mortensen J; Højgaard L; Lassen U Eur J Nucl Med Mol Imaging; 2011 May; 38(5):802-9. PubMed ID: 21210111 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer. Yap KK; Yap KS; Byrne AJ; Berlangieri SU; Poon A; Mitchell P; Knight SR; Clarke PC; Harris A; Tauro A; Rowe CC; Scott AM Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1033-40. PubMed ID: 15875178 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec. Nguyen VH; Peloquin S; Lacasse Y Can Respir J; 2005; 12(1):19-25. PubMed ID: 15776130 [TBL] [Abstract][Full Text] [Related]
8. Budget impact from the incorporation of positron emission tomography - computed tomography for staging lung cancers. Biz AN; Caetano R Rev Saude Publica; 2015; 49():57. PubMed ID: 26274871 [TBL] [Abstract][Full Text] [Related]
9. PET/CT in the staging of the non-small-cell lung cancer. Chao F; Zhang H J Biomed Biotechnol; 2012; 2012():783739. PubMed ID: 22577296 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective. Alzahouri K; Lejeune C; Woronoff-Lemsi MC; Arveux P; Guillemin F Clin Radiol; 2005 Apr; 60(4):479-92. PubMed ID: 15767106 [TBL] [Abstract][Full Text] [Related]
11. PET/CT for staging and monitoring non small cell lung cancer. Rankin S Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S27-31. PubMed ID: 18852078 [TBL] [Abstract][Full Text] [Related]
12. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754 [TBL] [Abstract][Full Text] [Related]
14. The PET and the pendulum. Margolis ML Ann Intern Med; 2009 Aug; 151(4):279-80. PubMed ID: 19581638 [No Abstract] [Full Text] [Related]
15. Endobronchial ultrasonography (EBUS)--its role in staging of non-small cell lung cancer and who should do it? Andrade RS; Odell DD; D'Cunha J; Maddaus MA J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S9-13. PubMed ID: 22898528 [No Abstract] [Full Text] [Related]
16. Cost effectiveness of positron emission tomography in Canada. Sloka JS; Hollett PD Med Sci Monit; 2005 Oct; 11(10):PH1-6. PubMed ID: 16192911 [TBL] [Abstract][Full Text] [Related]
17. Staging non-small lung cancer with positron emission tomography: diagnostic value, impact on patient management, and cost-effectiveness. Nosotti M; Castellani M; Longari V; Chella B; Baisi A; Rosso L; Santambrogio L Int Surg; 2008; 93(5):278-83. PubMed ID: 19943430 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA; Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081 [TBL] [Abstract][Full Text] [Related]
19. PET scanning is important in lung cancer; but it has its limitations. Navani N; Spiro SG Respirology; 2010 Nov; 15(8):1149-51. PubMed ID: 20920122 [No Abstract] [Full Text] [Related]
20. Performance of integrated positron emission tomography/computed tomography for mediastinal nodal staging in non-small cell lung carcinoma. Broderick SR; Patterson GA Thorac Surg Clin; 2013 May; 23(2):193-8. PubMed ID: 23566971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]